Cargando…
Pathophysiological Commonality Between Irritable Bowel Syndrome and Metabolic Syndrome: Role of Corticotropin-releasing Factor–Toll-like Receptor 4–Proinflammatory Cytokine Signaling
Irritable bowel syndrome (IBS) displays chronic abdominal pain with altered defecation. Most of the patients develop visceral hypersensitivity possibly resulting from impaired gut barrier and altered gut microbiota. We previously demonstrated that colonic hyperpermeability with visceral hypersensiti...
Autores principales: | Nozu, Tsukasa, Okumura, Toshikatsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Neurogastroenterology and Motility
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978123/ https://www.ncbi.nlm.nih.gov/pubmed/35189599 http://dx.doi.org/10.5056/jnm21002 |
Ejemplares similares
-
Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome
por: Nozu, Tsukasa, et al.
Publicado: (2019) -
Corticotropin-Releasing Hormone Receptor 1 Gene Variants in Irritable Bowel Syndrome
por: Sato, Naoko, et al.
Publicado: (2012) -
Corticotropin-Releasing Hormone Receptor 2 Gene Variants in Irritable Bowel Syndrome
por: Komuro, Hazuki, et al.
Publicado: (2016) -
Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome
por: Chatoo, Mahanand, et al.
Publicado: (2018) -
Corticotropin-Releasing Factor and Toll-Like Receptor Gene Expression Is Associated with Low-Grade Inflammation in Irritable Bowel Syndrome Patients with Depression
por: Jizhong, Song, et al.
Publicado: (2016)